# Medicxi Ventures Management (Jersey) Ltd: Form 13F holdings

An institutional investment manager in ST. HELIER. SEC CIK 1715579.

- Quarter ended: 2026-06-30
- Filed: 2026-08-04
- Reported value: $177.4m
- Positions: 3 (3 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1715579/000119312526332000/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [PHATHOM PHARMACEUTICALS INC (PHAT)](/companies/phat.md) | COM | $81.0m | 45.6% | 7,464,572 |  | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $74.9m | 42.2% | 2,208,639 |  | Reduced −465,543 |
| [AURA BIOSCIENCES INC (AURA)](/companies/aura.md) | COM | $21.6m | 12.2% | 3,039,892 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −19,963,157 |

Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-332000. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.